SOLITARY FIBROUS TUMORS

Clinical trials for SOLITARY FIBROUS TUMORS explained in plain language.

Never miss a new study

Get alerted when new SOLITARY FIBROUS TUMORS trials appear

Sign up with your email to follow new studies for SOLITARY FIBROUS TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New Triple-Action pill enters human testing in fight against tough cancers

Disease control Recruiting now

This is a first-in-human study to test the safety and find the right dose of a new oral drug, OKN4395, for people with advanced solid tumors. The trial will give the drug alone and combined with an existing immunotherapy (pembrolizumab) to about 166 participants with cancers like…

Matched conditions: SOLITARY FIBROUS TUMORS

Phase: PHASE1 • Sponsor: Epkin • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

SOLITARY FIBROUS TUMORS

Get alerted when new SOLITARY FIBROUS TUMORS trials appear

New Triple-Action pill enters human testing in fight against tough cancers